PACB - Pacific Biosciences of California - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PACB is currently covered by 7 analysts with an average price target of $2.74. This is a potential upside of $1.16 (73.42%) from yesterday's end of day stock price of $1.58.

Pacific Biosciences of California's activity chart (see below) currently has 145 price targets and 99 ratings on display. The stock rating distribution of PACB is 63.64% BUY and 36.36% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.26% with an average time for these price targets to be met of 256.94 days.

Highest price target for PACB is $3, Lowest price target is $2, average price target is $2.2.

Most recent stock forecast was given by LUKE SERGOTT from BARCLAYS on 15-Dec-2025. First documented stock forecast 27-Aug-2015.

Currently out of the existing stock ratings of PACB, 7 are a BUY (63.64%), 4 are a HOLD (36.36%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

$2

$0.39 (24.22%)

$1.5

2 months 9 days ago
(15-Dec-2025)

7/7 (100%)

$-0.12 (-5.66%)

12

Hold Since 07-Jan-2022

$2

$0.39 (24.22%)

$1.5

3 months 13 days ago
(11-Nov-2025)

11/11 (100%)

$0.14 (7.53%)

150

Buy Since 13-Dec-2023

$2

$0.39 (24.22%)

$1.8

3 months 14 days ago
(10-Nov-2025)

3/4 (75%)

$0.24 (13.64%)

150

Buy Since 13-Oct-2020

$3

4 months 9 days ago
(15-Oct-2025)

5/13 (38.46%)

$1.62 (117.39%)

123

Buy Since 03-Jun-2024

$3

$1.39 (86.34%)

9 months 15 days ago
(09-May-2025)

1/2 (50%)

$1.88 (167.86%)

40

Show more analysts

Please expand the browser size to see the chart

What is PACB (Pacific Biosciences of California) average time for price targets to be met?

On average it took 256.94 days on average for the stock forecasts to be realized with a an average price target met ratio 69.26

Which analyst has the current highest performing score on PACB (Pacific Biosciences of California) with a proven track record?

STEVEN MAH

Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?

Steven Mah has 7 price targets and 5 ratings on PACB

Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?

Steven Mah with highest potential upside - $50.39

Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?

John Sourbeer with lowest potential downside - -$0.11

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?